Search

everythinglearnresearchcommunity

for

Search:↓

Liver disease is linked to hair loss, especially in women and those with unhealthy lifestyles.

Recognizing rare causes of MASLD is crucial for effective treatment and preventing complications.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.

Long-term use of finasteride and dutasteride can cause serious health issues like diabetes and liver problems.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Restoring NAD⁺ may help with aging and chronic diseases, but more research is needed.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Lung and liver macrophages protect our tissues and their dysfunction can cause various diseases.

Liver damage in PCOS is linked to iron overload and cell death due to the miR-761-hepcidin/GPX4 pathway.

Hispanic women with PCOS are more likely to have liver diseases like NAFLD and NASH.

Sex hormones affect liver fat and metabolic health differently in men and women.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

BMI is a simple, cost-effective tool for screening obesity and related diseases.

New guidelines stress early diagnosis and lifestyle changes to manage metabolic syndrome and prevent complications.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Losing weight and eating better are key to managing metabolic syndrome and its related conditions.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Angelica gigas Nakai root extracts may help with cancer, pain, memory loss, and metabolic issues.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Skin problems are very common in people with end-stage kidney disease.

Higher basal metabolic rate increases the risk of non-alcoholic fatty liver disease, especially in Chinese people, and may require tailored management.